跳至主要内容
临床试验/IRCT20190726044339N4
IRCT20190726044339N4招募中3 期

Comparison of the effectiveness of lavender capsules (linazepam) with placebo in improving depression symptoms in patients with multiple sclerosis

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Men and women with Relapsing-remitting multiple sclerosis patients with aged between ??-?? years
  • Score above ?? according to Persian- version of the Beck Depression Inventory-II (BDI-II-Persian)

排除标准

  • Pregnancy and breastfeeding
  • Allergy to lavender
  • Unstable heart, kidney and liver patients
  • Hypothyroidism
  • Consumption of alcohol or drugs
  • Patients who do not follow the study completely
  • Patients with severe depression

研究者

相似试验